Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. 1994

T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
University of Tokushima, Japan.

A controlled cooperative study was carried out to assess the value of modified radical mastectomy for patients with stage II breast cancer. The data was analyzed from 11 institutions in the Shikoku District participating in a prospective clinical trial in which patients were randomly assigned either to a modified radical mastectomy group or an extended radical mastectomy group. These two groups of patients were similar to each other in terms of such background factors as age distribution, menopausal status, TNM classification, tumor size, location of the primary tumor, axillary nodal involvement, histological type, and estrogen receptor status. The median follow-up times in the modified and extended radical mastectomy groups were 4.7 and 4.5 years, respectively. The cumulative curves indicated no difference between the two groups in either disease-free survival or overall survival. The survival rates were classified according to the presence or absence of axillary nodal metastases. However, no significant difference was found between the two groups. These findings thus suggest that the routine removal of the grossly uninvolved major pectoral muscle and parasternal lymph nodes is not necessary in patients with stage II breast cancer.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
January 1990, Acta oncologica (Stockholm, Sweden),
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
March 1985, The New England journal of medicine,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
March 1985, The New England journal of medicine,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
January 1962, The American journal of roentgenology, radium therapy, and nuclear medicine,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
August 2002, The New England journal of medicine,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
January 1989, Cancer,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
August 1983, Annals of surgery,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
September 1963, American journal of surgery,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
March 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
T Morimoto, and Y Monden, and S Takashima, and S Itoh, and T Kimura, and H Yamamoto, and M Kitamura, and K Inui, and N Tanaka, and T Nagano
January 1976, Chirurgie; memoires de l'Academie de chirurgie,
Copied contents to your clipboard!